Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 144 participants.
Also called NCT07799129
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 144 participants
- Sponsor
- Eddingpharm (Zhuhai) Co., Ltd.
- Registry
-
NCT07799129
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07799129. Randomized; double masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia
- Condition
- Mixed Dyslipidemia
- Intervention (Drug)
- EDP167 100mg
- Intervention (Drug)
- EDP167 200mg
- Intervention (Drug)
- EDP167 300mg
- Lead sponsor
- Eddingpharm (Zhuhai) Co., Ltd.
Record details
- Record id
cardio:ct-nct07799129- Content hash
3df89ad65ef3e2ed5a72298e734280e146513591deecf8347f0644e8f3038812